Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vir Biotechnology Inc
(NQ:
VIR
)
10.62
+0.52 (+5.15%)
Streaming Delayed Price
Updated: 2:58 PM EDT, Jul 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vir Biotechnology Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
7 Top-Rated Stocks That Will Boost Your Portfolio in 2023
May 10, 2023
For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that.
Via
InvestorPlace
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
May 08, 2023
The World Health Organization ended the global emergency
Via
Benzinga
The 7 Best Bargain Stocks to Buy for May 2023
May 04, 2023
With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly.
Via
InvestorPlace
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 04, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
What 8 Analyst Ratings Have To Say About Vir Biotechnology
April 04, 2023
Via
Benzinga
Where Vir Biotechnology Stands With Analysts
February 24, 2023
Via
Benzinga
Vir Biotechnology's Earnings Outlook
February 22, 2023
Via
Benzinga
Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference
May 03, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention
May 02, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Why Shares of Keros Therapeutics Jumped This Week
April 21, 2023
The company appointed a new director and an analyst reiterated his position on the stock.
Via
The Motley Fool
Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...
Via
Benzinga
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
Via
Benzinga
Biotech Stocks And The SVB Collapse — Here's What We Know
March 14, 2023
The collapse of SVB will have a big impact on early-stage, venture-backed companies.
Via
Investor's Business Daily
Vir Biotechnology to Participate in the Barclays Global Healthcare Conference
March 08, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
March 06, 2023
Via
Benzinga
Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results
March 06, 2023
Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s...
Via
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.
Via
InvestorPlace
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
February 28, 2023
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
Via
Benzinga
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday
February 23, 2023
Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose...
Via
Benzinga
Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)
February 22, 2023
Final draft guidance based on cost effectiveness evaluation of sotrovimab
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.
Via
Benzinga
Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday
February 21, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 450 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Via
Benzinga
DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday
February 21, 2023
Wells Fargo boosted the price target for Deere & Company (NYSE: DE) from $485 to $510. Wells Fargo analyst Seth Weber maintained an Overweight rating on the stock. Deere shares fell 0.5% to $431.08 in...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.